CO58 Long-Term Health Outcomes in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil for 1 Year

The objective of this prespecified analysis was to assess health outcomes using the EuroQol Group Health Outcome Measure-five level (EQ-5D-5L) in patients who remained on AL for up to 1 year.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research